skip to Main Content

New imaging technology could buy time for pancreatic cancer patients

Newsfeed image, light gray text on dark gray background
Tumor shrinkage is one sign of cancer treatment’s efficacy—but Rochester scientists are exploring elasticity and permeability as well. The insidiousness of pancreatic cancer is how it develops without showing any definitive symptoms. In most cases, by the time it is diagnosed, it is beyond cure.

And yet, for 10 to 20 percent of patients, pancreatic cancer is caught soon enough, before it has metastasized. This provides surgeons a narrow window of time to try to treat the tumors, shrinking them enough to safely remove them. Read more . . . 


Back To Top